Версия для слабовидящих
Ру En Бел
Popular search
University Structure Academic departments Department of Obsterics and Gynecology Research activities

Publications

  1. Kukharchik J., Gutikova L. Serotonin and products of its degradation as predictor of noncarrying pregnancy in the I trimester // ISSC. 20 International students scientific conference for students and young doctors, Gdansk, 19-21 april 2012: abstract book.- Gdansk, 2012.- P.64.
  2. Kukharchik Yu.V. , Gutikova L.V. Pharmacological correction of a spontaneous abortion at women with noncarrying of pregnancy // Archives of Perinatal Medicine. – 2012. – № 18(2). – P. 117–119.
  3. The contribution of founder mutations in BRCA1 to breast cancer in Belarus // Uglanitsa N., Оszurek O., Uglanitsa К., Savonievich E., Lubnski  J., Cybulski C., Debniak T., Narod S.A., Gronwald J. // Clinical Genetics.- 2010.-Vol.78. – Р.377-380
  4. BRCA1 founder mutations compared to ovarian cancer in Belarus // Savanevich A., Oszurek O., Lubinski J., Сybulski C., Debniak T., Narod S., Gronwald .J. // Familian Cancer.- 2014.- № 13.-  С.445-447
  1. Kukharchyk Yu.V., Dubrouscaya V.V. Indicators of an exchange of catecholamines as diagnostic criteria of thret of a spontaneous abortion in the I trimester: 9th Warsaw international medical congress for young scietist, Warsaw, 9-12 may 2013 r // Archives of Medical Science.- , 2013.- № 1.- Р.255.
  2. Kukharchyk Y. Antioxidative activity of blood at unmaturing pregnancy // ISSC. 22 International students scientific conference for students and young doctors: abstract book.- Gdansk, 2014.- Р.216.
  3. Kukharchyk Y .V. Correction of threat of interruption of pregnancy of early terms // 1st Lublin International congress for medical students and young doctors.- Lublin, 2014.- Р.20.
  4. Gutikova L.V., Paulouskaya М.А., Kukharchyk Y.V. Immunohistoghemical testing of matrix metalloproteinase-9 and cyclin D1 in hypererplastic endometrium in women of reproductive age // 11 Congress of the European Society of Gynecology Congres de la Societe Europeenne de Gynecologie: abstract.- Prague, 2015.- Р.1.
  5. Hutsikava L., Kukharchyk Y. Preoperative preparation of women with uterine myoma // 17th World Congress on Human Reproduction, Rome, 15-18 March 2017. – Rome, 2017. – P. 31.
  6. Kukharchyk Y., Hutsikava L. Expression of vascular endothelial growth factor and Ki-67 in women with uterine myoma // 13th European days of the French society of gynecology, Paris, 2-4 February 2017. – P. 46.
  7. Rapid selection of BRCA-1 proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers  // Sokolenko A.P., Savonevich E.L., Ivantsov A.O., Raskin G.A., Kuligina E.S., Gorodnova T.V., Preobrazhenskaya E.V., Kleshchov M.A., Tiurin V.I., Mukhina M.S.,  Kotiv K.B., Shulga A.V., Kuznetsov S.G., Berlev I.V., Imyanitov E.N. // Cancer Letters. – 2017.- Vol.397.- P.127-132
  8. Somatic loss of the wild-type BRCA1 allele is not necessarily the first event in the pathogenesis of hereditary ovarian cancer: Implications for novel mechanism of acquired platinum resistance // Imyanitov E., Savonevich E., Ivantsov A., Raskin G., Kuligina E., Gorodnova T., Preobrazhenskaya E., Kleshchov M., Tiurin V., Togo A., Sokolenko A. // Annals of Oncology. – Vol. 28. Suppl. 5.- P. 582-583.
  9. Loss of heterozygosity at the BRCA1 locus as a marker of sensitivity for adjuvant chemotherapy in hereditary ovarian cancer // Savonevich E.L., Sokolenko A.P. Stepuro T.L. Shulga A.V.Berlev I.V.Imyanitov E.N. // Biological Markers in Fundamental and Clinical Medicine. – 2017.- Vol.1 №3. – Р.29-31.

 

  1. Kukharchik J., Gutikova L. Serotonin and products of its degradation as predictor of noncarrying pregnancy in the I trimester // ISSC. 20 International students scientific conference for students and young doctors, Gdansk, 19-21 april 2012: abstract book.- Gdansk, 2012.- P.64.
  2. Kukharchik Yu.V. , Gutikova L.V. Pharmacological correction of a spontaneous abortion at women with noncarrying of pregnancy // Archives of Perinatal Medicine. – 2012. – № 18(2). – P. 117–119.
  3. The contribution of founder mutations in BRCA1 to breast cancer in Belarus // Uglanitsa N., Оszurek O., Uglanitsa К., Savonievich E., Lubnski  J., Cybulski C., Debniak T., Narod S.A., Gronwald J. // Clinical Genetics.- 2010.-Vol.78. – Р.377-380
  4. BRCA1 founder mutations compared to ovarian cancer in Belarus // Savanevich A., Oszurek O., Lubinski J., Сybulski C., Debniak T., Narod S., Gronwald .J. // Familian Cancer.- 2014.- № 13.-  С.445-447
  1. Kukharchyk Yu.V., Dubrouscaya V.V. Indicators of an exchange of catecholamines as diagnostic criteria of thret of a spontaneous abortion in the I trimester: 9th Warsaw international medical congress for young scietist, Warsaw, 9-12 may 2013 r // Archives of Medical Science.- , 2013.- № 1.- Р.255.
  2. Kukharchyk Y. Antioxidative activity of blood at unmaturing pregnancy // ISSC. 22 International students scientific conference for students and young doctors: abstract book.- Gdansk, 2014.- Р.216.
  3. Kukharchyk Y .V. Correction of threat of interruption of pregnancy of early terms // 1st Lublin International congress for medical students and young doctors.- Lublin, 2014.- Р.20.
  4. Gutikova L.V., Paulouskaya М.А., Kukharchyk Y.V. Immunohistoghemical testing of matrix metalloproteinase-9 and cyclin D1 in hypererplastic endometrium in women of reproductive age // 11 Congress of the European Society of Gynecology Congres de la Societe Europeenne de Gynecologie: abstract.- Prague, 2015.- Р.1.
  5. Hutsikava L., Kukharchyk Y. Preoperative preparation of women with uterine myoma // 17th World Congress on Human Reproduction, Rome, 15-18 March 2017. – Rome, 2017. – P. 31.
  6. Kukharchyk Y., Hutsikava L. Expression of vascular endothelial growth factor and Ki-67 in women with uterine myoma // 13th European days of the French society of gynecology, Paris, 2-4 February 2017. – P. 46.
  7. Rapid selection of BRCA-1 proficient tumor cells during neoadjuvant therapy for ovarian cancer in BRCA1 mutation carriers  // Sokolenko A.P., Savonevich E.L., Ivantsov A.O., Raskin G.A., Kuligina E.S., Gorodnova T.V., Preobrazhenskaya E.V., Kleshchov M.A., Tiurin V.I., Mukhina M.S.,  Kotiv K.B., Shulga A.V., Kuznetsov S.G., Berlev I.V., Imyanitov E.N. // Cancer Letters. – 2017.- Vol.397.- P.127-132
  8. Somatic loss of the wild-type BRCA1 allele is not necessarily the first event in the pathogenesis of hereditary ovarian cancer: Implications for novel mechanism of acquired platinum resistance // Imyanitov E., Savonevich E., Ivantsov A., Raskin G., Kuligina E., Gorodnova T., Preobrazhenskaya E., Kleshchov M., Tiurin V., Togo A., Sokolenko A. // Annals of Oncology. – Vol. 28. Suppl. 5.- P. 582-583.
  9. Loss of heterozygosity at the BRCA1 locus as a marker of sensitivity for adjuvant chemotherapy in hereditary ovarian cancer // Savonevich E.L., Sokolenko A.P. Stepuro T.L. Shulga A.V.Berlev I.V.Imyanitov E.N. // Biological Markers in Fundamental and Clinical Medicine. – 2017.- Vol.1 №3. – Р.29-31.
  10.